ACCC and Lilly Announce Seven Awardees of the Healthcare Improvement Initiative “Improving the Precision Oncology Care Pathway”

ROCKVILLE, Md., March 18, 2025 /PRNewswire/ — The Association of Cancer Care Centers (ACCC), in collaboration with Eli Lilly and Company, is pleased to announce the seven recipients of the “Improving the Precision Oncology Care Pathway” Request for Proposals (RFP).

The grant program invited community hospital-based programs and physician group practices to apply for grants to develop targeted, actionable solutions, based on quality improvement methodology, to effectively address patient loss along the precision oncology care pathway.

Awardees

The following cancer programs have been selected to receive funding for their innovative proposals:

“Precision medicine requires a deep understanding of the nuances of tumor molecular testing, but also a systematic plan for implementation and integration into everyday practice,” said ACCC member Stacey Cohen, MD. “Through this grant program, ACCC member programs and practices are offered a unique opportunity to explore quality improvement initiatives that expedite the implementation and sustainability of precision oncology efforts within their own health systems.”

“Lilly is committed to supporting initiatives that foster the translation of scientific evidence into clinical practice and improve patient outcomes,” said Kara Clinton, Senior Vice President of Oncology Global Medical Affairs, Eli Lilly and Company.  “This initiative was an opportunity for Lilly to collaborate with ACCC to support community healthcare systems in addressing barriers preventing optimal biomarker-informed cancer care and ensure more patients can benefit from precision oncology.” 

Addressing Clinical Gaps in Precision Oncology

This grant program asked that oncology programs identify site-specific challenges and develop clear, actionable strategies to  address them, with a strong emphasis on improving patient care. The funded proposals are designed to:

  • Analyze and address key healthcare gaps in patient outcomes, system processes, and/or healthcare provider performance.
  • Implement measurable interventions to reduce variation and improve care quality for patients with solid tumors.
  • Demonstrate interdisciplinary collaboration to achieve long-term impact.

About ACCC

The Association of Cancer Care Centers (ACCC) is the leading advocacy and education organization for the multidisciplinary cancer care team. More than 45,000 cancer care professionals from over 1,700 hospitals and practices nationwide are affiliated with ACCC. Providing a national forum for addressing issues that affect community cancer programs, ACCC is recognized as the premier provider of resources for the entire oncology care team. Our members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, pharmacists, oncology nurses, radiation therapists, social workers, and cancer program data managers. For more information, visit ACCC’s website at www.accc-cancer.org. Follow us on Facebook, X, LinkedIn, and read our blog, ACCCBuzz.

View original content to download multimedia:https://www.prnewswire.com/news-releases/accc-and-lilly-announce-seven-awardees-of-the-healthcare-improvement-initiative-improving-the-precision-oncology-care-pathway-302404870.html

SOURCE Association of Cancer Care Centers (ACCC)

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

11 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

20 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

23 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

23 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

23 hours ago